Cognitive behavioral therapy
Behavioralexercise therapy
Other names: physical therapy
NCT Number: NCT03319355
Therapy for fibromyalgia is a well discussed topic in literature, yet not thoroughly evidence-based. Several unicomponent therapies seem to be benificial. Whereas multicomponent and multidisciplinary therapy gains importance and revealing promising results, the investigators aim to combine two well-known therapies in a program for patients with fibromyalgia.
From clinical experience, a high drop-out rate has been stated. All data will be explored to analyse explanatory factors.
Looking for future studies?
Notify Me20 year–50 year
Female
Interventional
Not applicable
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
exercise therapy
Other names: physical therapy
Time frame: 6weeks
impact of fibromyalgia on daily life with a questionnaire
Time frame: 6weeks
rating the kinesiophobia with a questionnaire
Time frame: 6 weeks
degree of depression with a questionnaire
Time frame: 6 weeks
inventory of the use of pain coping strategies with a questionnaiire
Time frame: 6 weeks
measuring tolerable pain at specified tenderpoints with an algometer
Time frame: 6 weeks
measuring grip strength of both hands with a dynamometer
Time frame: 6 weeks
6 minute walking test on a treadmill
Time frame: 6 weeks
10 minutes cycling test on a hometrainer
University Ghent
Other
The Effect of a 12-week Multicomponent Therapy in Fibromyalgia
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05998369
Abdominal Pain, Autonomic Nervous System Diseases
Palo Alto, California, United States
View Trial DetailsNCT06752590
Fibromyalgia, Muscular Diseases
Nagakute, Aichi-ken, Japan
View Trial DetailsNCT05237050
Chronic Pain, Fibromyalgia
Gap, Hautes Alpes, France
View Trial DetailsNCT07665411
Fibromyalgia, Muscular Diseases
Covilha, Castelo Branco District, Portugal
View Trial Details